Esophagitis dissecans: a rare cause of odynophagia.
Patel
N K
NK
Department of Gastroenterology, St. Thomas' Hospital, Guy's and St. Thomas' NHS Trust, London, United Kingdom.
Salathé
C
C
Vu
C
C
Anderson
S H
SH
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D003680:Deglutition Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003937:Diagnosis, Differential; D004941:Esophagitis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D004945:Esophagoscopy; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D009092:Mucous Membrane / Q000187:drug effects / Q000473:pathology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014456:Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab